← Insider Monitor
VOLITIONRX LTD logo
VNRX

VOLITIONRX LTD

NYSE · In Vitro & In Vivo Diagnostic Substances

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

VolitionRx Limited develops blood-based diagnostic tests that detect nucleosomes and other biomarkers to screen for cancers and other diseases, including its Nu.Q platform aimed at colorectal cancer and other conditions.

Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Henderson, NV
Exchange
NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Reynolds Cameron JohnPresident and CEOBuy$7KNov 19, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for VNRX.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable VNRX activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.